once-MONTHLY bisphosphonate called Boniva (ibandronate)

You'll hear about the new once-MONTHLY bisphosphonate called Boniva (ibandronate) this month. It's a 150 mg tablet.

A 2.5 mg Boniva was approved over a year ago, but never marketed. The company was waiting for approval on monthly dosing. Otherwise they'd have no significant advantage over weekly Actonel or Fosamax.

All the costs are roughly comparable.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote